Invention Grant
US08404717B2 Methods of treating myelodysplastic syndromes using lenalidomide
有权
使用来那度胺治疗骨髓增生异常综合征的方法
- Patent Title: Methods of treating myelodysplastic syndromes using lenalidomide
- Patent Title (中): 使用来那度胺治疗骨髓增生异常综合征的方法
-
Application No.: US13070761Application Date: 2011-03-24
-
Publication No.: US08404717B2Publication Date: 2013-03-26
- Inventor: Jerome B. Zeldis
- Applicant: Jerome B. Zeldis
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/445
Abstract:
Methods of treating, preventing and/or managing myelodysplastic syndromes are disclosed. Specific methods encompass the administrations of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidin-2,6-dione in combination with 5-azacytidine.
Public/Granted literature
- US20110172273A1 METHODS OF TREATING MYELODYSPLASTIC SYNDROMES USING LENALIDOMIDE Public/Granted day:2011-07-14
Information query
